Sunshine Biopharma (SBFM) Cash from Investing Activities (QoQ) (2017 - 2026)
Sunshine Biopharma (SBFM) Cash from Investing Activities (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95.10% |
| Mar 31, 2026 | -108.17% |
| Dec 31, 2025 | 57.56% |
| Sep 30, 2025 | 74.05% |
| Jun 30, 2025 | -114.98% |
| Mar 31, 2025 | -116.85% |
| Dec 31, 2024 | 85.42% |
| Sep 30, 2024 | -23.68% |
| Jun 30, 2024 | 18.92% |
| Mar 31, 2024 | -148.39% |
| Dec 31, 2023 | -1,527.59% |
| Sep 30, 2023 | 107.27% |
| Jun 30, 2023 | -77.36% |
| Mar 31, 2023 | 99.00% |
| Dec 31, 2020 | 51.13% |
| Dec 31, 2019 | 40.28% |
| Sep 30, 2019 | 88.90% |
| Dec 31, 2018 | -89.38% |
| Sep 30, 2018 | 456.12% |
| Jun 30, 2018 | 71.88% |